Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06663878 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years 11 months later Mar 2026 → Mar 2031
See other at-risk trials from Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Record History

  1. Primary completion pushed from Mar 2026 to Mar 2031
    • Trial status changed: Not Yet Recruiting → Active, Not Recruiting
    • Start date changed from estimate of Oct 2024 to Oct 28, 2024
    • Site contact updated
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this study is to evaluate the tolerability and safety of MWAV201 in patients with Wilson disease.
Trial Details
NCT Number NCT06663878
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators: Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions
(from sponsor)		 Wilson Disease
Related terms Hepatolenticular Degeneration
Enrollment 9 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov